Literature DB >> 11324698

HLA, molecular mimicry and multiple sclerosis.

R Liblau1, A M Gautam.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system in which an autoimmune response most probably contributes to pathogenesis. To date, the best characterized susceptibility-associated gene has been mapped to the HLA complex. The HLA-DRB1*1501 - DRB5*0101 - DQA1*0102 - DQB1*0602 haplotype is both associated and linked to MS in different ethnic groups. The locus within the HLA class II region encoding the MS-susceptibility gene is under intensive investigation. Epidemiological studies, however, have suggested that environmental antigens also play a critical role in MS pathogenesis. One of the ways a pathogen could trigger autoimmune disease is via immunological cross-reactivity or molecular mimicry. This concept argues that a microbial peptide with certain degree of homology to a self peptide can stimulate pathogenic self-reactive specific T cells to cause an autoimmune disease. Many microbial agents have regions of sequences that may serve as binding motifs for HLA-DR2. HLA genetics and molecular mimicry may therefore be intimately interlinked in the disease process. In the present review, we focus on the HLA association with MS and the role of microbial antigens in MS, with special reference to the molecular mimicry hypothesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324698

Source DB:  PubMed          Journal:  Rev Immunogenet        ISSN: 1398-1714


  8 in total

1.  Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells.

Authors:  Zsolt Illés; Joel N H Stern; Jayagopala Reddy; Hanspeter Waldner; Marcin P Mycko; Celia F Brosnan; Stephan Ellmerich; Daniel M Altmann; Laura Santambrogio; Jack L Strominger; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

Review 2.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

3.  Case Report: Postvaccination Anti-Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder: A Case Report and Literature Review of Postvaccination Demyelination.

Authors:  Neha Kumar; Kelsey Graven; Nancy I Joseph; John Johnson; Scott Fulton; Robert Hostoffer; Hesham Abboud
Journal:  Int J MS Care       Date:  2020 Mar-Apr

Review 4.  Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.

Authors:  Monica J Carson
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

5.  Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Authors:  Dominique Le Houézec
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 6.  The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels.

Authors:  B A 't Hart; H P Brok; S Amor; R E Bontrop
Journal:  Hum Immunol       Date:  2001-12       Impact factor: 2.850

7.  Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children.

Authors:  Hyun Hee Oh; Soon Hak Kwon; Chang Woo Kim; Byung Ho Choe; Cheol Woo Ko; Hee Du Jung; Jang Soo Suh; Jun Hwa Lee
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

8.  Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients.

Authors:  Annie Boucher; Marc Desforges; Pierre Duquette; Pierre J Talbot
Journal:  Clin Immunol       Date:  2007-04-19       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.